These findings establish a new framework for understanding gene–environment interactions in metabolic disease and highlight ADCY3 as a tractable target for rhythm-based interventions aimed at improving metabolic resilience and reducing obesity risk in genetically susceptible individuals. Here, ADCY3 is linked to Other metabolic disease.